News and Events

Four physician-scientist trainees describe their lives and careers and how they have made the most of opportunities presented by COVID-19.

Duke University is among the “Best Employers for Women” in 2020, according to Forbes, which released rankings on Tuesday.

A multi-disciplinary scientific advisory board will provide rapid readouts of data on epidemiology, infection transmission rates, and other research. The pilot project, which is funded by the NIH, creates a model with potential to expand to additional school districts across the nation.

Michael Deel, MD, assistant professor of pediatrics in the Division of Hematology-Oncology and member of the Duke Cancer Institute, has dedicated his career to studying this fusion-positive rhabdomyosarcoma, with a goal of giving patients a better shot at a long and healthy life.

Emmanuel (Chip) B. Walter, MD, MPH, pediatric infectious diseases specialist, is principal investigator on a clinical trial for a SARS-COV-2 (COVID-19) vaccine. Geeta Swamy, MD, maternal-fetal medicine specialist, is co-investigator.

New and competing renewal awards made to faculty in the Department of Pediatrics through the month of June 2020 are announced.

Dr. Chi Hornik is the Director of Clinical Research in the Division of Pediatric Critical Care Medicine. She is a clinician in neonatal and pediatric critical care, a pharmacotherapy specialist, and has faculty appointments in the Duke School of Medicine and the Duke Clinical Research Institute. Hornik talks about her diverse responsibilities as a clinician, researcher, and mentor, how COVID-19 has affected her work and personal life, and how she became interested in pediatrics and pediatric critical care and neonatal medicine in particular.

The Doris Duke Charitable Foundation (DDCF) recently announced the 17 physician scientists, including Andrew Landstrom, MD, PhD, assistant professor of pediatrics and cell biology, who are each receiving a 2020 Clinical Scientist Development Award of $495,000 over three years.

The decision to reopen schools is complicated and nuanced and should consider the specific needs and public health situations of individual communities, Duke health experts said Tuesday. Speaking to reporters during a virtual media briefing, two pediatricians and an applied economist explained the many difficult aspects to consider when deciding whether to reopen schools to children this fall.

In an article in Healthline,  Dr. Joseph A. Jackson, a pediatrician at Duke University School of Medicine, is interviewed about how and when parents can talk with their children about race, racism, freedom, and black liberation